Berberine: A Plant Alkaloid with Therapeutic Potential for Central Nervous System Disorders

被引:293
|
作者
Kulkarni, S. K. [1 ]
Dhir, Ashish [2 ]
机构
[1] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
[2] Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA
关键词
berberine; monoamines; neurological disorders; safety; CONGESTIVE-HEART-FAILURE; COPTIDIS-RHIZOMA EXTRACT; INDUCED DIABETIC-RATS; FORCED SWIM TEST; NITRIC-OXIDE; ANTIDEPRESSANT ACTIVITY; HIPPOCAMPUS; MECHANISM; EFFICACY; CHLORIDE;
D O I
10.1002/ptr.2968
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Berberine, an isoquinoline alkaloid of the protoberberine type found in an array of plants, has been used in Indian and Chinese medicines as an antimicrobial, stomachic, bitter tonic and in the treatment of oriental sores. Although pharmacological investigations of berberine have been reported by many in the past, there is renewed interest in berberine because of its reported beneficial effect in various neurodegenerative and neuropsychiatric disorders. The alkaloid is reported to modulate neurotransmitters and their receptor systems in the brain. This review attempts to discuss the pharmacological basis of the use of berberine in various central nervous system and related disorders. Its protective effect in Alzheimer's, cerebral ischemia, mental depression, schizophrenia and anxiety are highlighted. However, more detailed clinical trials along with a safety assessment of berberine are warranted for positioning the alkaloid in the treatment of neurological disorders. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 50 条
  • [21] Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
    Kazuki Terada
    Keisuke Migita
    Yukari Matsushima
    Chiaki Kamei
    Neural Regeneration Research, 2019, 14 (11) : 1893 - 1894
  • [22] Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology
    Ona, Genis
    Carlos Bouso, Jose
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (01) : 53 - 68
  • [23] Metalloporphyrins as Therapeutic Catalytic Oxidoreductants in Central Nervous System Disorders
    Sheng, Huaxin
    Chaparro, Raphael E.
    Sasaki, Toshihiro
    Izutsu, Miwa
    Pearlstein, Robert D.
    Tovmasyan, Artak
    Warner, David S.
    ANTIOXIDANTS & REDOX SIGNALING, 2014, 20 (15) : 2437 - 2464
  • [24] PHARMACOLOGICAL ACTIONS OF BERBERINE ON CENTRAL NERVOUS SYSTEM
    SHANBHAG, SM
    KULKARNI, HJ
    GAITONDE, BB
    JAPANESE JOURNAL OF PHARMACOLOGY, 1970, 20 (04): : 482 - &
  • [25] The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders
    Costales, Jesse
    Kolevzon, Alexander
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 63 : 207 - 222
  • [26] RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders
    Guha, Abhishek
    Husain, Mohammed Amir
    Si, Ying
    Nabors, L. Burt
    Filippova, Natalia
    Promer, Grace
    Smith, Reed
    King, Peter H.
    GLIA, 2023, 71 (03) : 485 - 508
  • [27] A potential therapeutic target: The role of neutrophils in the central nervous system
    Salken, Isabel
    Provencio, Jose Javier
    Coulibaly, Aminata P.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2023, 33
  • [28] Prostaglandins in the Inflamed Central Nervous System: Potential Therapeutic Targets
    Sheremeta, Chynna-Loren
    Yarlagadda, Sai
    Smythe, Mark L.
    Noakes, Peter G.
    CURRENT DRUG TARGETS, 2024, 25 (13) : 885 - 908
  • [29] Functions and therapeutic potential of nitric oxide in Central Nervous System
    Adan, A
    Prat, G
    PSICOTHEMA, 2005, 17 (02) : 275 - 280
  • [30] Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers
    Gurunathan, Sangiliyandi
    Kang, Min-Hee
    Kim, Jin-Hoi
    CANCERS, 2020, 12 (06) : 1 - 25